People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Butterflymx, Inc. | — | Other Technology | Series C | $68.2M | $1.0B | 2018 |
| Quadrant Biosciences Inc | — | Biotechnology | Series B | $37.4M | $240.8M | 2019 |
| Polarityte, Inc. | — | Biotechnology | Series B | $24.0M | $69.4M | 2022 |
Peter Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gorlin | 1 | 11 |
| Roger Hurwitz | 1 | 7 |
| Robert Chefitz | 1 | 7 |
| MICHAEL BRAUSER | 1 | 6 |
| Barry Honig | 1 | 6 |
| Andrew Rock | 1 | 4 |
| SUKEN VAKIL | 1 | 4 |
| John Stetson | 1 | 3 |
| Aaron Rudenstine | 1 | 3 |
| Kunal Shah | 1 | 2 |
| Richard Hague | 1 | 2 |
| Mohit Bhansali | 1 | 2 |
| Jon Mogford | 1 | 2 |
| Patrick Bailey | 1 | 2 |
| Nicholas R. Silvers | 1 | 2 |
| Nicholas Silvers | 1 | 2 |
| Ira Dowd Fedder | 1 | 1 |
| Cindy Dowd Greene | 1 | 1 |
| Richard K. Bongo | 1 | 1 |
| James Croke | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.